Analyst ratings and price targets can significantly influence the market's perception of a stock. In this case, the 'Outperform' rating maintained by Raymond James, coupled with an increased price target, indicates a positive outlook for Harmony Biosciences. This could potentially lead to an increase in the stock's price in the short term.